Drug information for VALSARTAN AND HYDROCHLOROTHIAZIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 160MG; 25MG Tentative Approval   VALSARTAN; HYDROCHLOROTHIAZIDE Exforge HCT MYLAN PHARMA 78020
TABLET; ORAL 160MG;12.5MG Tentative Approval   VALSARTAN; HYDROCHLOROTHIAZIDE Exforge HCT MYLAN PHARMA   "
TABLET; ORAL 320MG; 12.5MG Tentative Approval   VALSARTAN; HYDROCHLOROTHIAZIDE Exforge HCT MYLAN PHARMA   "
TABLET; ORAL 320MG; 25MG Tentative Approval   VALSARTAN; HYDROCHLOROTHIAZIDE Exforge HCT MYLAN PHARMA   "
TABLET; ORAL 80MG;12.5MG Tentative Approval   VALSARTAN; HYDROCHLOROTHIAZIDE Exforge HCT MYLAN PHARMA   "

Drug Adverse Effects information for VALSARTAN AND HYDROCHLOROTHIAZIDE

Role code Indications Reaction # Reports
C ACUTE LEUKAEMIA CYTOLYTIC HEPATITIS 2
C ACUTE LEUKAEMIA DIALYSIS 2
C ACUTE LEUKAEMIA FEBRILE BONE MARROW APLASIA 2
C ACUTE LEUKAEMIA RENAL FAILURE 2
C ACUTE LEUKAEMIA SEPTIC SHOCK 2
C ACUTE LEUKAEMIA VENOOCCLUSIVE LIVER DISEASE 2
C LEUKAEMIA CYTOLYTIC HEPATITIS 1
C LEUKAEMIA DIALYSIS 1
C LEUKAEMIA FEBRILE BONE MARROW APLASIA 1
C LEUKAEMIA RENAL FAILURE 1
C LEUKAEMIA SEPTIC SHOCK 1
C LEUKAEMIA VENOOCCLUSIVE LIVER DISEASE 1
C TYPE 2 DIABETES MELLITUS BLADDER TRANSITIONAL CELL CARCINOMA 1
Ads by Google